Full-Time

Controls and Automation Engineer

Synthomer

Synthomer

1,001-5,000 employees

Global producer of specialized aqueous polymers

No salary listed

Company Does Not Provide H1B Sponsorship

Rock Hill, SC, USA

In Person

On-site role in Chester, South Carolina; USC

Bachelor's

Category
Electrical Engineering (1)

Get referred to Synthomer

See people who can refer or advise you

Requirements
  • Degree in Electrical & Electronic Engineering, Instrumentation, Control Automation, Chemical Engineering or equivalent, with minimum 5 years’ experience in related field.
  • Experience in execution of capital projects through lifecycle, developing and maintaining best engineering practice, facilitating technology selection, and continuous improvement.
  • Ability to select the appropriate execution strategy and develop budgets for Control and Automation elements.
Responsibilities
  • Provide full support to ensure projects are delivered within time, to budget and to the required quality.
  • Develop conceptual designs with respect to key equipment requirements and required technology needs, while working with internal and external specialists.
  • Prepare basic and detailed engineering documentation as required to support the execution of projects.
  • Design and specify C&A Engineering for new projects with the responsible engineer for the project.
  • Responsible for checking & approval of third-party design work & documents to ensure compliance to Synthomer standards.
  • Provide C&A Engineering cost estimates to Project Managers. Ensure all related information is suitably documented and updated.
  • Organize and participate in risk assessments and safety studies of designs.
  • Support construction activities to ensure the project is delivered as per the design.
  • Prepare test plans, procedures and functional progress reports to ensure on time delivery of plant mechanical completion.
  • Actively supports the commissioning team and start-up activities through to handover to end user.
  • Identify and analyze plant engineering problem and recommend cost effective solutions to resolve them.
  • Conduct process control optimization studies and implement the required rectification measures in line with operation needs.
  • Identify and improve procedures for control system maintenance for efficiency and increased reliability.
  • Supports the development and implementation of Engineering Best Practices throughout the region.
  • Delivers functional engineering in line with the Global Project Framework.
  • Provides engineering support activities for manufacturing facilities.
  • Carry out plant capacity and productivity studies as well as execute process improvement activities.
  • Ensures all engineering work meets the required company standards and statutory compliance.
  • Proposes best available technology that will aid cost reduction, improvement in production quality, reduction of energy and total asset life cycle costs.
  • URS and FDS for Control systems, with appropriate architecture and standardization.
  • Selection of suitable hardware and software for DCS and SIS.
  • Coding and execution of changes and set up of control logic.
  • Provide engineering support activities for manufacturing facilities as required.

Synthomer develops and supplies aqueous polymer dispersions and specialised polymers for coatings, construction, adhesives, textiles, paper and health-related products. These polymers are designed and manufactured to deliver adhesion, durability and compatibility with different substrates, and are tailored to each customer’s processes and performance requirements. The company differentiates itself through a global footprint and a focus on high-performance, customised solutions rather than off-the-shelf products, with close collaboration with customers. Its goal is to help customers achieve their performance targets by providing reliable, high-quality polymers and expanding its global reach in key markets.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

London, United Kingdom

Founded

1908

Get referred to Synthomer

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • H1 2026 revenue rose 6.7% to £954.3 million, with EBITDA up 16.4%.
  • Management raised FY26 EBITDA guidance to about £162 million after strong H1.
  • Three additional divestments target £150 million to £200 million, accelerating deleveraging.

What critics are saying

  • The Mutares Acrylate Monomers sale closes only by Q3 2026, delaying debt relief.
  • £6 million H1 gains came from temporary NBR disruptions, not durable demand.
  • If divestments stall, Synthomer's leverage blocks investment and forces distressed asset sales.

What makes Synthomer unique

  • Synthomer sells specialty polymers across coatings, construction, adhesives, and health, not commodity bulk.
  • August 2026 interim results show EBITDA margin improved to 10.1%, proving pricing power.
  • Godavari partnership and Acrylate divestment sharpen the portfolio toward lower-carbon specialty monomers.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

15%

1 year growth

15%

2 year growth

15%
Sharecast
Aug 4th, 2026
Synthomer lifts FY outlook after strong first half.

Synthomer lifts FY outlook after strong first half. 92.70p. 15:21 04/08/26. Chemicals company Synthomer lifted its full-year outlook on Tuesday following a strong first half. 7,949.14. 5,863.20. 8,127.96. 15:22 04/08/26. In the six months to 30 June, underlying operating profit rose 41.7% to £48.6m, with revenue up 6.7% at £954.3m and all divisions contributing growth. Revenue in Coatings & Construction Solutions (CCS) was up 33.3% at £46m, while revenue from Adhesive Solutions (AS) edged up 3.7% to £36.7m. The Health & Protection and Performance Materials business (HPPM) saw revenues rise 13.7% to £24.9m. Earnings before interest, tax, depreciation and amortisation increased 16.4% to £96.7m. Synthomer said it now expects its FY26 performance to be "slightly ahead" of market expectations for EBITDA of £162m. This reflects a strong first half, led by strategic growth and self-help, supporting further progress in the second half despite ongoing geopolitical uncertainties, it said. Chief executive Michael Willome said: "Synthomer has delivered a strong performance so far in 2026, with the majority of the progress Sharecast has made coming from its sustained efforts to become a more speciality-focused company and its consistent work to 'control the controllables'. This includes its focus on growing its higher margin products and accessing new markets, customer-led innovation, optimising its regional manufacturing strategy and further cost and complexity reductions. "While our agility and ability to deliver helped our customers navigate the challenging operating conditions in Q2, the market environment will continue to require us to be fast and bold. We are confident that by remaining true to our speciality strategy, we will continue to strengthen our balance sheet and deliver further sustainable earnings growth." At 1130 BST, the shares were up 5.4% at 93.78p. Broker Peel Hunt, which rates the shares at 'buy' with a 200p price target, said H1 EBITDA was ahead of its estimate of £88m. It increased its 2026 EBITDA forecast from £160m to £165m. "The route to the medium-term targets, coupled with debt normalisation, is looking increasingly well established," it said. "We view 200p as a realistic next-step target."

Finimize
Aug 4th, 2026
Synthomer raises its outlook after cost cuts pay off.

Synthomer raises its outlook after cost cuts pay off. The UK specialty chemicals firm lifted its full-year profit and cash flow view after first-half core profit rose 13.4% to £96.7 million. about 1 hour ago - 2 mins What's going on here? Synthomer, a UK specialty chemicals firm, raised its full-year profit and cash flow outlook after first-half core profit rose 13.4% to £96.7 million, sparking a sharp rally in its shares. What does this mean? Synthomer makes polymers used in coatings, adhesives, and medical gloves, and it says its turnaround is starting to show in the numbers. Cost cuts and a tilt toward higher-margin specialty products helped lift first-half core profit to £96.7 million as revenue rose nearly 7% to £954.3 million, according to Reuters. The company now expects 2026 core profit to come in slightly ahead of market expectations and says it's on track for positive free cash flow... Keep reading for free. This content is free, but you must be logged in to continue reading. Already have an account?

LGG Industrial
Jul 21st, 2026
Jeff Chaapel joins LGG Industrial as Vice President & General Manager, U.S. West Region.

Jeff Chaapel joins LGG Industrial as Vice President & General Manager, U.S. West Region. Published by LGG Industrial. Pittsburgh, PA - LGG Industrial is pleased to announce the appointment of Jeff Chaapel as Vice President & General Manager, U.S. West Region. Chaapel brings nearly 30 years of progressive leadership experience. Most recently, Chaapel served as Vice President of Energy Solutions at Synthomer, where he spent the past 13 years building and scaling an incubated business into a global market leader. "Jeff's depth of industry knowledge and leadership experience make him an excellent fit for LGG Industrial," said Jeff Crane, Chief Executive Officer of LGG Industrial. "We are very excited to welcome him to the LGG Industrial team." In this role, Jeff will provide strategic leadership for the West Region's sales strategy and growth opportunities. Lewis-Goetz & Co Inc is excited to welcome Jeff Chaapel to LGG Industrial and look forward to the leadership and experience he will bring to its organization. About LGG Industrial LGG Industrial is the go-to partner for industrial companies looking for fluid handling, sealing, and material conveyance solutions. Headquartered in Pittsburgh, Pennsylvania and supported by Luther King Capital Management, LGG Industrial has decades of experience creating value for the North American industrial market with a passion for customer service that is met with deep technical know-how.

AD HOC NEWS
Jul 11th, 2026
Mutares Juggles Two Major Deals as Dividend Does Little to Shore Up Share Price

Mutares shares fall 10% YTD despite €2 dividend; technicals bearish. Firm races to close Synthomer

European Coatings
Jun 19th, 2026
Synthomer divests acrylate monomers business to Mutares.

Synthomer divests acrylate monomers business to Mutares. Synthomer has announced the divestment of its acrylate monomers business, marking a strategic move to simplify its portfolio and focus on speciality chemicals. The Czech-based business will transition to Mutares, a private equity firm specialising in company turnarounds. 19 June 2026 Synthomer, a leading global supplier of high-performance polymers, has confirmed the divestment of its acrylate monomers business in the Czech Republic. The business, which operates under Synthomer a.s., will be acquired by Mutares, a Munich-based private equity company with expertise in transforming industrial businesses. This decision is part of Synthomer's strategic shift towards a streamlined portfolio centred on speciality chemicals with higher margins and growth potential. Acrylate Monomers, a key supplier of acrylic acid and related monomers to the European market, employs approximately 300 staff at its Sokolov manufacturing site. The site also contributes to Synthomer's downstream operations by supplying acrylic monomers to Group companies and producing acrylic dispersions. Under the new ownership, these supply arrangements will remain intact. Strategic portfolio simplification The divestment reflects Synthomer's strategy to exit highly cyclical and capital-intensive sectors. Acrylate Monomers was the last remaining upstream business in Synthomer's portfolio and had been designated as non-core following a strategic review in October 2022. Michael Willome, CEO of Synthomer, stated, "This announcement is another important step in delivering our strategy to simplify our business and sharpen our focus on higher-margin, higher-growth speciality chemicals markets where we have strong and sustainable leadership positions." He expressed confidence in Mutares' ability to steer Acrylate Monomers through its next phase of development. Financial dynamics and transaction details In 2025, Acrylate Monomers reported external sales of EUR 68 million but faced an adjusted EBITDA loss of EUR 10 million. Improved trading conditions in early 2026, influenced by short-term market fluctuations and cost reductions, led the business to a break-even point. Synthomer noted that Acrylate Monomers requires approximately EUR 5 million annually in capital expenditure, highlighting its capital-intensive nature. The transaction, expected to close at the end of Q3 2026, includes a cash generation sharing arrangement of up to EUR 12 million over three years, with no initial payment at closing. To ensure operational continuity, the divested company will receive EUR 5 million in cash for working capital requirements.